Moneycontrol PRO
HomeNewsIndiaCOVID-19 second wave | Health, job and children's education: What urban Indians are more worried about

COVID-19 second wave | Health, job and children's education: What urban Indians are more worried about

Almost three in four urban Indians say they are worried about the COVID-19 pandemic having negative long-term effects on society.

June 01, 2021 / 09:27 IST
Image by Eakachai Leesin via Shutterstock

Amid the second wave of COVID-19 pandemic, urban Indians are more worried about their health and slightly less worried about their finances as compared to the situation a year ago.

According to a survey by YouGov conducted among 1,500 urban Indians, around 68 percent said they were worried about friends or family members becoming seriously sick or dying. That number was around 56 percent in May 2020 – just a few months after the pandemic started.

About 68 percent said that they were worried about their finances being severely affected. That figure was slightly higher at 71 percent during the same time last year.

As many as 73 percent of respondents said that they worry about the COVID-19 pandemic having negative long-term effects on society. Though, that number remained unchanged since last year.

Personal health concerns soar

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

However, the number of respondents saying that they were worried about themselves becoming seriously ill or dying due to the novel coronavirus infection increased significantly – from 45 percent in May 2020 to 64 percent now.

Urban Indians have also become increasingly worried about the possibility of losing their job. The number of respondents who said losing employment was a matter of concern for them stood at 54 percent, as compared to 45 percent a year ago.

Infographic: What Worries Indians Most in the COVID Crisis | Statista

Similarly, the number of respondents who said they were worried about their children's education suffering had also increased.

The survey suggests that public trust had fallen when it came to trusting what was being said by healthcare professionals, the government, friends and family, and the media.

Follow our LIVE blog for the latest updates of the coronavirus pandemic

India, one of the worst affected countries due to the pandemic, is battling the second wave of COVID-19 infections. As of May 31, the country had reported 2.80 crore COVID-19 cases. While 2.56 crore patients had recovered, 20.26 lakh cases remained ‘active’. The death toll from the outbreak stood at 3.29 lakh.

While daily infections had fallen since mid-May, the impact of lockdown-like restrictions imposed across most states to curb the further spread of the infectious disease has caused widespread economic disruption.

While rapid mass vaccination of the population is being seen as the only way to end the pandemic and return to normalcy, a severe shortage of COVID-19 vaccine doses has hampered the inoculation drive in most states – further slowing the reopening process.

Follow Moneycontrol’s full coverage of the coronavirus pandemic here

Moneycontrol News
first published: Jun 1, 2021 09:27 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347